Results 291 to 300 of about 938,469 (359)

Equitable access to essential medicines to treat neglected tropical diseases: Latest developments from the World Health Organization (WHO). [PDF]

PLoS Negl Trop Dis
Fattah F, Lester R, Kalua K, Sharp B, Wasan KM.   +4 more
europepmc   +1 more source

Hidden Risks of Taking Generic Drugs over Brand Name: The Impact of Drug Labeling Regulations on Injured Consumers and the Pharmaceutical Industry

, 2014
Samantha Koopman
openalex   +1 more source

Whole-Genome Sequencing and Antimicrobial Resistance Analysis of Enterotoxigenic <i>Escherichia coli</i> F5 and F5-F41 Strains Isolated from Neonatal Calves in Inner Mongolia, China. [PDF]

Animals (Basel)
Xie M, Shang H, Lv L, Liu P, Li W, Wang D, Yuan Y, Huang T, Wang X, Xu X.   +9 more
europepmc   +1 more source

Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study

Manthana Laichapis, Rungpetch Sakulbumrungsil, Khunjira Udomaksorn, Nusaraporn Kessomboon, Osot Nerapusee, Charkkrit Hongthong, Sitanun Poonpolsub   +6 more
openalex   +1 more source

Nonclinical regulatory considerations for investigational new drug applications for regulatory T cell therapies. [PDF]

Front Med (Lausanne)
Dinh PU, Mihalcik L.
europepmc   +1 more source

The impact of the Drug Marketing Authorization Holder system on sustainable improvement of innovation quality in the pharmaceutical manufacturing industry in China—An empirical study using synthetic control methods

Qiuzhuo Liu, Su Wang, Zhe Huang
openalex   +1 more source

Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricing.

BMJ
Kaló Z, Kruja K, Noone D, Vogler S, Docteur E.   +4 more
europepmc   +1 more source

[Fewer new drugs from drug industry].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2008
openaire   +1 more source